Patents by Inventor Jeong Kyo Yoon

Jeong Kyo Yoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION FOR PREVENTING OR TREATING MUSCLE DISEASE CONTAINING CXCL 14 AS AN ACTIVE INGREDIENT
    Publication number: 20250161410
    Abstract: The present disclosure relates to a composition for preventing or treating muscle disease, comprising CXCL14 as an active ingredient. According to the present disclosure, it was confirmed that CXCL14 increased muscle differentiation and synthesis, thereby increasing muscle mass. In addition, it was confirmed that in LPS-induced muscular atrophy or DEX-induced muscular dystrophy, CXCL14 inhibited muscle loss, increased the expression of muscle synthesis and differentiation factors, and inhibited the expression of muscle degradation proteins. In addition, it was confirmed that CXCL14 promoted muscle synthesis and differentiation and inhibited the muscle degradation even in vivo.
    Type: Application
    Filed: November 6, 2024
    Publication date: May 22, 2025
    Applicant: SOONCHUNHYANG UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION
    Inventor: Jeong-kyo YOON
  • Cristin/R-spondin ligands active in the Wnt signaling pathway and methods, compositions and kits relating thereto
    Patent number: 7541431
    Abstract: The present invention relates to compositions and method for the modulation of Wnt pathway signaling. The Wnt signaling pathway is instrumental in the regulation of cell proliferation, differentiation and morphogenesis.
    Type: Grant
    Filed: August 17, 2006
    Date of Patent: June 2, 2009
    Assignee: Maine Medical Center
    Inventor: Jeong Kyo Yoon